Albuquerque-based company lands patent for novel Alzheimer’s technology

The approval is for a "method patent," said Kristina Trujillo, TNeuroPharma's CEO. It's licensed exclusively to TNeuroPharma for the company's method of detecting T-cells in patients to diagnose and treat Alzheimer's.

Its former downtown S.F. office was a ‘buzzkill,’ so fintech finds splashy new use for its space

Longtime Wynwood developer proposes new office project (Photos)

Morrisville pharma sees revenue soar as monkeypox spreads

Container Store planning to join Whole Foods at Springfield Plaza

Shares in Bethesda’s Enviva fall 13% following report from short-seller Blue Orca Capital

The Post opens new take-out only restaurant in the Highlands

On the Agenda: Mansfield to vote on agreement with Hoque Global for a $50M mixed-use project

4 Texas social media influencers indicted in $114 million securities fraud scheme, feds say

Albuquerque-based company lands patent for novel Alzheimer’s technology

Previous C-Suite Awards: A Q&A with Allie Quick, Allegheny Health Network

Next Business Coalition on Health hits 10th anniversary with 50 members, 1.5 million covered lives

firststargroup

Kotek touts $500M Oregon housing plan at Leadership Summit

Retirement plans see boost as states mandate IRAs and tax credits lower costs

Norton Healthcare data breach affected more than 2 million people

Houston-based cell therapy company FibroBiologics files to go public

Suggested Posts

CBF Morning Run: What you need to know today and it’s curling season!

BrewDog sets opening date for massive Cincinnati taproom and restaurant

New York ranks No. 1 in losing residents to other states

Aurora neighborhood retail strip center sells for $3.75M

Changes ahead for Bank of Akron

Bankrupt Caribbean Paradise Woos Chinese Tourists—and Their Cash

MENU

FirstStar Group

More Stories

Visa’s new currency conversion rules boost Euronet stock to 52-week high